| abstract |
The present invention relates to a human type antibody which is capable of avoiding tissue factor (Factor F3) signaling but does not interfere with Factor VII binding and FX binding to tissue factor and does not prolong clotting time. The anti-system of the invention is useful in the treatment of, for example, symptoms of tumor progression in which the relevant cells exhibit tissue factor and tissue factor signaling occurs. |